GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » EV-to-EBITDA

Colinz Laboratories (BOM:531210) EV-to-EBITDA : 10.76 (As of Dec. 13, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Colinz Laboratories's enterprise value is ₹96.78 Mil. Colinz Laboratories's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₹8.99 Mil. Therefore, Colinz Laboratories's EV-to-EBITDA for today is 10.76.

The historical rank and industry rank for Colinz Laboratories's EV-to-EBITDA or its related term are showing as below:

BOM:531210' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3.24   Med: 9.66   Max: 24.07
Current: 10.77

During the past 13 years, the highest EV-to-EBITDA of Colinz Laboratories was 24.07. The lowest was -3.24. And the median was 9.66.

BOM:531210's EV-to-EBITDA is ranked better than
60.36% of 719 companies
in the Drug Manufacturers industry
Industry Median: 14.28 vs BOM:531210: 10.77

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-13), Colinz Laboratories's stock price is ₹67.12. Colinz Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹2.120. Therefore, Colinz Laboratories's PE Ratio (TTM) for today is 31.66.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Colinz Laboratories EV-to-EBITDA Historical Data

The historical data trend for Colinz Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories EV-to-EBITDA Chart

Colinz Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.26 -0.41 7.98 4.30 3.70

Colinz Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 12.77 3.70 12.74 8.21

Competitive Comparison of Colinz Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Colinz Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's EV-to-EBITDA falls into.



Colinz Laboratories EV-to-EBITDA Calculation

Colinz Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=96.783/8.991
=10.76

Colinz Laboratories's current Enterprise Value is ₹96.78 Mil.
Colinz Laboratories's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Colinz Laboratories  (BOM:531210) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Colinz Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=67.12/2.120
=31.66

Colinz Laboratories's share price for today is ₹67.12.
Colinz Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.120.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Colinz Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Colinz Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India based company engaged in trading and manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories Headlines

No Headlines